Skip to content
Skip to main navigation
Skip to first column
Skip to second column
Hong Kong Respiratory Medicine
Joint Website of HKTS, ACCP HK & Macau, HKLF
The Lancet and the Lancet series of journals
HK Thoracic Society
ACCP (HK & Macau Chapter)
HK Lung Foundation
About us
The Lancet and the Lancet series of journals
Title Filter
Display #
5
10
15
20
25
30
50
100
All
#
Article Title
Hits
1
2012 Feb-4 Optimising therapy for EGFR-addicted NSCLC: just the start
1
2
2012 Jan-8 A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies
18
3
2012 Jan-8 Beyond first-line NSCLC therapy: chemotherapy or erlotinib?
10
4
2012 Jan-8 Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
32
5
2012 Jan-8 Surgical treatment of drug-resistant tuberculosis
20
6
2012 Jan-22 Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden
14
7
2012 Jan-8 EGFR exon 20 insertion mutations in non-small-cell lung cancer: preclinical data and clinical implication
63
8
2012 Jan-8 Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives
62
9
2011 Dec-25 Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives
46
10
2011 Dec-25 Tests for prediction of active tuberculosis
72
11
2011 Dec 25 Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis
15
12
2011 Dec-25 Estimating the effect of influenza vaccines
69
13
2011 Dec-25 Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysi
43
14
2011 Dec 12 - β-agonists for ARDS: the dark side of adrenergic stimulation?
105
15
2011 Dec-17 Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial
76
16
2011 Dec-10 Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study
128
17
2011 Dec-4 Serotype replacement in disease after pneumococcal vaccination
101
18
2011 Dec-4 DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials
81
19
2011 Nov-26 Autoimmune diseases and risk of pulmonary embolism
124
20
2011 Nov-26 Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden
86
21
2011 Nov-11 Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial
91
22
2011 Nov-6 EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study
121
23
2011 Oct-30 The global rise of extensively drug-resistant tuberculosis: is the time to bring back sanatoria now overdue?
99
24
2011 Oct-30 Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
122
25
2011 Oct-22 Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial
120
26
2011 Oct-22 Point-of-care tuberculosis diagnosis: are we there yet?
189
27
2011 Oct-22 Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study
67
28
2011 Sep-25 Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis
150
29
2011 Sep-10 Controversies in treatment of chronic obstructive pulmonary disease
196
30
2011 Sep-10 The future of chronic obstructive pulmonary disease treatment—difficulties of and barriers to drug development
233
31
2011 Sep-10 New insights into the immunology of chronic obstructive pulmonary disease
158
32
2011 Sep-10 Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial
147
33
2011 Sep-10 Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study
148
34
2011 Sep-10 Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial
210
35
2011 Aug-20 Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis
157
36
2011 Aug-20 Prevention of ventilator-associated pneumonia with oral antiseptics: a systematic review and meta-analysis
167
37
2011 Aug-20 Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis
162
38
2011 Aug-14 Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial
200
39
2011 July-31 Prevention of ventilator-associated pneumonia with oral antiseptics: a systematic review and meta-analysis
214
40
2011 July-31 Palaeogenomics of Mycobacterium tuberculosis: epidemic bursts with a degrading genome
181
41
2011 July-31 Fact and fiction in tuberculosis vaccine research: 10 years later
241
42
2011 July-23 EGFR exon 20 insertion mutations in non-small-cell lung cancer: preclinical data and clinical implications
261
43
2011 July- 23 Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study
233
44
July 2011 July- 23 Erlotinib, gefitinib, or chemotherapy for EGFR mutation-positive lung cancer?
406
45
2011 July-23 Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
203
46
2011 July-2 Surgery for mesothelioma? The debate continues
267
47
2011 July-2 Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study
101
48
2011 July-2 Idiopathic pulmonary fibrosis
288
49
2011 July-2 Text messaging in smoking cessation: the txt2stop trial
239
50
2011 July-2 Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trial
134
51
2011 June 25- The European Respiratory Roadmap
176
52
201 June 25- Outpatient management of pulmonary embolism
320
53
2011 June 25- Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial
317
54
2011 June 25- Tuberculosis
174
55
2011 June 25- Non-small-cell lung cancer
215
56
2011 June 25- Small-cell lung cancer
119
57
2011 June-19 Use of a WHO-recommended algorithm to reduce mortality in seriously ill patients with HIV infection and smear-negative pulmonary tuberculosis in South Africa: an observational cohort study
154
58
2011 June-19 Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial
196
59
2011 June-19 Palaeogenomics of Mycobacterium tuberculosis: epidemic bursts with a degrading genome
220
60
2011 June-12 Glucocorticoid treatment in community-acquired pneumonia
298
61
2011 June-12 Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial
161
62
2011 May 29- Tuberculosis and cancer: a complex and dangerous liaison
352
63
2011 May 29- Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis
184
64
2011 May 29- Salvage with erlotinib plus bevacizumab: not in NSCLC
295
65
2011 May 29- Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial
201
66
2011 May 15 - Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
364
67
2011 May 7- 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial
148
68
2011 May 2- Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study
243
69
2011 Apr 13 - Lancet Comment: Isoniazid preventive therapy in HIV infection
370
70
2011 Mar 23 - Viral pneumonia
260
71
2011 Mar 16 - Prevalence of Heavy Smoking in California and the United States, 1965-2007
231
72
2011 Mar 18 - Tuberculosis
247
73
2011 Feb 16 - Lancet Comment: Cell-culture-derived influenza vaccine production
524
74
2011 Feb 16 - Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial
246
75
2011 Feb 15 - Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial
364
76
2011 Feb 15 Lancet Comment: New insights into the treatment of persistent asthma
473
77
2011 Jan - Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study
395
78
2011 Jan 6 - Lancet Comment: Vitamin D nutrient to treat TB begs the prevention question
690
79
2011 Jan 6 - High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial
506
80
2011 Jan - First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy: a subgroup analysis of data from the FLEX phase 3 study
354
81
2010 Dec 17 - Head-to-head comparison of pandemic influenza vaccines
466
82
2010 Dec 17 - Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial
322
83
2010 Dec 17 - Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial
326
84
2010 Nov 23 - Influenza in young children: burden, immunisation, and policy
279
85
2010 Nov 23 - Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study
265
86
2010 Dec 9 - Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study
399
87
2010 Nov 26 - Second-hand smoke's worldwide disease toll
439
88
2010 Nov 26 - Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries
431
89
2010 Nov 2 - Priorities for tuberculosis research: a systematic review
338
90
2010 Nov 1 - Aerosol drug delivery: developments in device design and clinical use
375
91
2010 Oct 14 - Genetics of lung-cancer susceptibility
375
92
2010 Oct 12 - New driver mutations in non-small-cell lung cancer
422
93
2010 Oct - Tuberculosis case-contact research in endemic tropical settings: design, conduct, and relevance to other infectious diseases
339
94
2010 Oct 4 - Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a cluster-randomised trial
322
95
2010 Oct 4 - Lancet Comment: Active case-finding for TB in the community: time to act
482
96
2010 Sep 1 - Scale-up of diagnostics for multidrug resistant tuberculosis
481
97
2010 Sep 1 - Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis
423
98
2010 Sep 4 - The role of dendritic and epithelial cells as master regulators of allergic airway inflammation
455
99
2010 Sep 4 - Role of viral respiratory infections in asthma and asthma exacerbations
391
100
2010 Sep 4 - Management of severe asthma in children
475
«
Start
Prev
1
2
Next
End
»
Page 1 of 2
Main Menu
Home
Subcommittees
Activities
Public and Media Contact
Grants & Scholarships
Special Occasions
Research
Useful Links
Administrators' Area (Requires Login)
Who's Online
We have 11 guests online
Statistics since July 2009
Content View Hits
: 535098
Twenty Most Read Articles
2009 Dec - Nursing Management of Chest Drains (14832)
2010 Jan - Revised Lung Cancer Staging (2009) - Rationale and Changes (14140)
2008 Positive Expiratory Pressure (PEP) Therapy (5943)
2010 世界胸肺年– 香港胸肺基金會謝婉雯醫生紀念獎學金 中學生公開徵文比賽 (5758)
About us (4932)
HKTS Council Members (4373)
2001 - What is respiratory exchange ratio (RER)? What is respiratory quotient (RQ)? (4230)
Useful Links (4210)
2008 What are the Advantages and Disadvantages of Each Aerosol Delivery Device? Is There Any Benefit of One Over Another? (3854)
Editorial of the Newsletter - A trimonthly joint communiqué of Hong Kong Thoracic Society & American College of Chest Physicians (Hong Kong and Macau Chapter) (3704)
2010 May - Early Rehabilitation in Intensive Care Unit (3614)
2009 Preoperative Assessment Before Lung Resection Surgery (3312)
2002 Sep - What is trapped lung and how to manage it? (3302)
ACCP (HK & Macau Chapter) Council Members (3115)
2010 Jun - Safety of Talc Pleurodesis (2908)
2011 Jul 8 to 11 - 3rd Asia Pacific Region Conference of the International Union Against Tuberculosis and Lung Disease (IUATLD) (2906)
2010 Jun - Exercise Testing in COPD Patients (2897)
2007 How do you diagnose airflow obstruction on spirometry? (2671)
2005 Medical management of pneumothorax (2632)
Editorial Board Members (2452)